-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Suspends Neutral Rating on Crinetics Pharmaceuticals

Benzinga·09/02/2026 10:36:56
语音播报
Cantor Fitzgerald suspends Neutral rating on Crinetics Pharmaceuticals (NASDAQ:CRNX).